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Integrated microfluidic systems with sample preparation and nucleic acid 
amplification
Juxin Yina, Yuanjie Suoa, Zheyu Zou a, Jingjing Suna, Shan Zhanga, Beng Wangbf, Yawei Xuc, Diane Darlandd※, Julia Xiaojun 
Zhaoe※, Ying Mu a※
Rapid, efficient and accurate nucleic acid molecule detection is important in the screening of diseases and pathogens, yet 
remains a limiting factor at point of care (POC) treatment. Microfluidic systems are characterized by fast, integrated, 
miniaturized features which provide an effective platform for qualitative and quantitative detection of nucleic acid 
molecules. The nucleic acid detection process mainly includes sample preparation and target molecule amplification. Given 
the advancements in theoretical research and technological innovations to date, nucleic acid extraction and amplification 
integrated with microfluidic systems has advanced rapidly. The primary goal of this review is to outline current approaches 
used for nucleic acid detection in the context of microfluidic systems. The secondary goal is to identify new approaches that 
will help shape future trends at the intersection of nucleic acid detection and microfluidics, particularly with regard to 
increasing disease and pathogen detection for improved diagnosis and treatment.
Introduction
Molecular diagnosis is a technique that uses molecular biology 
methods to detect changes in the structure or level of 
expression of patient-derived genetic material. This technique 
involves nucleic acid amplification testing (NAAT) technology. 
With the high demand for rapid detection tools for diseases and 
pathogens in the fields of medicine and food safety, the focus 
has been directed towards molecular diagnostic approaches for 
Point of Care (POC). POC is an approach that involves analyzing 
samples at the site of sample collection, thereby reducing the 
time required for diagnosis and eliminating (or reducing) the 
need to transfer specimens to offsite testing laboratories 1-5. 
The rapid turnaround for POC diagnosis usually does not require 
professional personnel, such as clinical examiners, for sample 
processing and analysis. Compared with traditional laboratory 
detection methods, POC primarily achieves portable in-situ 
detection partially completed by technical staff which 
streamlines operational procedures, integrates detection 
devices, and reduces detection costs 6-8. The microfluidic chip 
technology, also known as the micro Total Analysis System 
(µTAS) was first proposed by Manz and colleagues in the 1990s 
9. With more than twenty years of development, it has become 
an independent area of biochemical analysis. The microfluidic 
chip has features such as rapid and efficient analysis, low 
consumption, and miniaturization. Moreover, it has the ability 
to perform nucleic acid extraction and detection on a single 
chip, thereby providing an excellent platform for POC 10, 11. 
Figure 1 highlights the conceptual intersection of technical 
improvements for nucleic acid isolation and amplification with 
the microfluidics platform. Improvement at any of these critical 
technical points confers additive advancements that directly 
contribute to improved POC and increased treatment efficiency 
(Fig. 1).
To provide real-time diagnosis of diseases and early screening 
for diseases 12-14, it is important to develop techniques that 
allow for accurate and rapid detection of nucleic acids, including 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which 
may reveal the contamination of pathogens in food and the 
environment as well as the emergence of tumor markers using 
tissue scrapes and biopsies. Indeed, the discovery of circulating 
nucleic acids has allowed for fast, accurate, and cost-effective 
detection of nucleic acids, thereby playing an increasingly 
important role in the early diagnosis of disease 15-17. Traditional 
nucleic acid detection methods have several challenges, 
including lengthy preparation and analysis time, vulnerability to 
contamination, sensitivity limitations, and complex procedures 
and operation. Collectively, these challenges limit the 
effectiveness of these methods in POC. Integration of 
microfluidic technology with nucleic acid extraction helps to 
address previous technical and analytical limitations associated 
with nucleic acid detection. 
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The development of nucleic acid detection technology based on 
the microfluidic chip has greatly improved the diagnostic 
efficiency and accuracy of various diseases 18, 19. NAAT based on 
the microfluidic chip has the advantages of being highly 
sensitive and specific, while still providing a user-friendly 
workflow with good qualitative and quantitative detection 
potential 20-22. A specific example of this is the Integrated nucleic 
acid extraction, amplification, and Detection (INEAD) system 
developed by combining microfluidic applications in POC and 
clinical diagnosis. The chip can be used for sample preparation, 
nucleic acid signal amplification, and quantification of results on 
a single device, which actualizes the goal of "sample-in-answer 
out". The entire procedure is performed in a closed 
environment, which reduces the burden on the operator and 
addresses the need for rapid detection without time and 
location constraints. 
In this review, we will focus on current methods for extraction 
of nucleic acids in microfluidic systems and advanced methods 
for nucleic acid amplification implemented in microfluidic 
systems. Furthermore, we will introduce current technologies 
and approaches integrating the INEAD system and provide an 
outlook for future technological approaches.
2. Current methods in nucleic acid isolation and 
purification
Nucleic acid extraction is the "first step" in molecular 
diagnostics and nucleic acid detection for research applications. 
The extraction of nucleic acids mainly refers to the separation 
of nucleic acids from biological macromolecules such as 
proteins, polysaccharides, and fats. The following target goals 
are associated with nucleic acid extraction: to ensure the 
integrity of the primary structure of nucleic acid molecules is 
preserved; to exclude other molecular contaminants; and to 
optimize yield. Sample lysis (whether from whole tissue, cells, 
or blood samples) and nucleic acid adsorption are necessary 
steps for nucleic acid extraction. The quality and efficiency of 
nucleic acid extraction directly influence the research results or 
diagnostic output. In many situations, nucleic acid extraction 
time accounts for a higher fraction of the total time spent during 
the detection process, and hence greatly affects the efficiency 
of the entire detection process. Any mistakes during the 
extraction process may inhibit the downstream applications 
such as polymerase chain reaction (PCR) or alternative 
amplification approaches as well as the purity of the end 
product 23. This also poses a huge challenge to quality and 
consistency. Application of microfluidic systems overcomes this 
limitation and improves nucleic acid extraction efficiency 
through the precise design, automation, and single system 
approach 24-26. Here we highlight nucleic acid extraction 
methods that are based on microfluidic systems, and identify 
their advantages and limitations.
2.1 Isolation of nucleic acids by Magnetic Beads
Magnetic beads are formed by coating a core of Fe3O4 with an 
active group that can be adsorbed by a magnet and then bind 
to nucleic acids in a cell or tissue lysate 21, 27, 28. The combination 
of beads with nucleic acids is controlled by adjusting the pH or 
the salt concentration 29. High flux, automated extraction of 
nucleic acids is achieved by applying magnetic beads in synergy 
with other bead compositions, such as silicon 30. Their compact 
size, ease of handling, and high efficiency when used to isolate 
nucleic acids make magnetic beads suitable for microfluidic 
platform applications 27, 31-33. The following factors contribute to 
the efficiency of magnetic beads for nucleic acid extraction. (1) 
The magnetic force on the surface of the magnetic beads. (2) 
The strength of the magnetic field. It should be emphasized 
here that the force is proportional to the magnetic field gradient 
and not the magnetic field intensity. (3) The binding capacity of 
the magnetic beads with the nucleic acid. Prior studies have 
demonstrated the importance of magnetic beads in isolating 
RNA. For example, Shi et al. proposed a Total RNA Extraction 
Droplet Array (TREDA) system for RNA purification. The authors 
have developed a system that uses hydrophilic spots to hold 
stationary droplets and uses magnets to control the movement 
of magnetic beads between droplets (Fig. 2A). This approach 
can extract total RNA in a low cell concentration medium in less 
than 5 minutes and the product can be used readily for 
quantitative real-time PCR (qPCR) platforms 34. This approach is, 
therefore, highly amenable to simultaneous extraction of 
multiple samples and the extraction of trace samples from 
complex sources.  
Surface tension is an important parameter in the application of 
magnetic beads in microfluidic chips since it can achieve the 
separation of different extraction components at the 
microscopic scale 35-37. Mosley et al. revealed the potential of 
magnetic beads to extract nucleic acids from complex samples 
using a microfluidic system (Fig. 2B). They leveraged surface 
tension to separate reagents and employed an external 
magnetic field to control the movement of magnetic beads to 
achieve DNA extraction from stool samples. In this study, the 
authors used mineral oils with better biocompatibility to 
separate different components, and chose the appropriate lysis 
buffer (5M Guanidinium hydrochloride, GuHCl) optimized to the 
amount of magnetic beads for efficient nucleic acid extraction 
38. Shu et al. 39 proposed an Active Droplet-Array (ADA) 
approach in which the reagents are pre-stored in water-in-oil 
form and the oil phase infiltrates the micro-cells and slits while 
the aqueous phase is excluded due to surface tension. 
Meanwhile, lysis, washing, elution, and detection are 
accomplished by automatically controlling the movement of 
beads in the droplet array. The latter system provides the 
magnetic beads with automation control and reduces handling-
related contamination issues.
The magnetic bead method is suitable for automated extraction 
and many commercial automatic nucleic acid extractors are 
based on this method such as MagNA Pure96 (RocheTM), Smart 
LabAssist-32 (TAN BeadTM), BioRobot MDx (QIAGEN), and SPRI-
TE (Beckman). The magnetic bead-based nucleic acids 
extraction process is rapid and results in high-efficiency 
extraction when integrated with microfluidic platforms. The 
advantage of magnetic beads combined with microfluidic 
platforms in automated extraction of nucleic acids is likely to 
promote the development of molecular diagnostics in the 
future. However, the control of magnetic beads is still a difficult 
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challenge and requires a complicated control system to achieve 
automation. This technical limitation renders most of the 
current products to be bulky and costly, which limits its 
application in POC and other clinical applications. It is also 
important to note that nucleic acid extraction should be 
performed in an absolutely closed environment to prevent 
exogenous contamination. At present, although certain 
measures have been developed to prevent contamination, 
some products are still vulnerable to contamination.
2.2 Silicon-based method of nucleic acid isolation
Silica is widely used in DNA extraction because of its stability, 
biocompatibility, and easy modification properties, especially in 
Solid Phase Extraction (SPE) 40, 41. Being an important sample 
pretreatment and enrichment technology, the application of 
SPE in microfluidic chips has attracted much attention and is an 
effective strategy for integrating nucleic acids in microfluidic 
devices 42-44. The target nucleic acid molecule combines with the 
silica-based material that is modified on the microfluidic chip in 
the presence of high chaotropic salt concentration 45-47. The 
bound nucleic acids can be washed with the appropriate 
solution, such as diluted ethanol or isopropanol, and then 
quickly eluted by a small amount of solvent to extract the target 
nucleic acid 48. Different forms of silicon have been utilized in 
the microfluidic system for nucleic acid extraction. In 1999, 
Christel et al.49 demonstrated that silicon fluidic microchips 
could be used for DNA extraction. In this study, thousands of 
micropillars with a silica surface were fabricated by deep 
reactive ion etching on a silicon wafer, which increased the 
internal surface area of the chip. Ramsey’s group 50 applied silica 
membranes for the concentration of DNA on the microfluidics 
which allowed for DNA fragments to be concentrated up to 2 
orders of magnitude. Petralia et al. used silica-coated pillar 
arrays on microchips to extract DNA (Fig. 3A) and reported that 
elution efficiency strongly depended on the geometrical 
dimensions of the pillars and efficiency increased with the 
surface/volume ratio 51. Park et al. 48 developed a complete 
rotating microfluidic system using silicon beads as a material for 
DNA extraction (Fig 3B). The authors applied the geometrical 
depth on the chip so that reaction liquid was stored in the chip, 
and the precise design of the microfluidic system and rotational 
speed control could ensure that each step progressed smoothly. 
Based on this method, they integrated DNA extraction and 
amplification into a centrifugal chip and detected 50 colony 
forming units (CFU) of pathogens within 80 minutes. Gunal et 
al. 52 used monodisperse-porous silica microspheres on the 
microfluidic system to isolate 14 ng DNA from 10μL of whole 
blood lysate, further demonstrating the value of silicon-based 
approaches in nucleic acid isolation.
On-chip silicon solid-phase extraction technology not only 
reduces the complexity of the analysis and the time required, 
but also promotes the integration and miniaturization of 
analytical instruments. However, nucleic acid extraction based 
on this method produces more waste liquid; therefore, a 
suitable waste liquid storage area has to be designed on the 
microfluidic chip to prevent or reduce pollution. Moreover, 
microfluidic nucleic acid extraction based on this method 
requires relatively complex equipment such as those required 
for manufacturing of the chips, which limits the application of 
this method.
2.3 Paper-based method of nucleic acid isolation
Paper, a new branch of microfluidic technology, is an attractive 
and inexpensive platform (Lab-on-a-paper) for nucleic acid 
extraction due to its inherent advantages such as 
biocompatibility, high surface area, and absorptive nature 53-55. 
A filter paper consisting of lysis reagent and protein 
denaturation reagent can be used to store reagents in a dried 
form for long periods without refrigeration 19, 56, 57. Commercial 
filter papers have been launched in the market, including 
products such as 903® paper and a Fast Technology Analysis 
(FTA)® card 58. The pores of filter paper not only affect the 
binding of nucleic acids (such as DNA) but also influence the 
post-preparation processes such as PCR efficiency and stability. 
These are the two major challenges of using paper-based 
microfluidic chips for nucleic acid extraction 59. One of the 
common methods of nucleic acid extraction by paper-based 
microfluidic chips involves the use of lysis buffer and extraction 
buffer in the reservoir module 60, 61. Chitosan is used to prevent 
the inhibitory effects of guanidine and isopropanol on PCR and 
it can be applied in nucleic acid extraction with paper-based 
microfluidic chips 62. Gan et al (Fig. 4) developed a chitosan-
modified Fusion 5 filter paper by embedding it in a 
thermoplastic microchip. This highly efficient approach 
leveraged the principle of the entanglement of DNA with fibers 
and the electrostatic adsorption of DNA to chitosan polymers 63. 
This idea is similar in principle to the approach proposed by 
Byrnes et al, who developed a porous chitosan membrane that 
could purify and concentrate DNA from complex samples 64. To 
extract RNA, Roriguez et al. 65 proposed an alcohol precipitation 
method based on a polyethersulfone (PES) filter paper. The 
filter paper was used to detect H1N1 from human clinical 
nasopharyngeal specimens. The fastest nucleic acid extraction 
has been achieved using a filter paper (Whatman No.1). Filter 
paper allows rapid extraction and purification of nucleic acids 
from plants, animals and microorganisms within 30 seconds at 
a very low cost 66. As a result, this technology can be used to 
extract DNA and RNA without specialized equipment. 
Over the years, researchers in different fields have been using 
several methods for nucleic acid extraction from paper 
technology. This technology can extract nucleic acids from 
samples with different viscosities such as raw viscous samples 
67, urine 68, and bacteria solutions 69. Optimization of paper-
based microfluidic chips will help increase the efficiency and 
decrease the cost of nucleic acid extraction. In addition, several 
studies have revealed that nucleic acid amplification methods 
(such as PCR, LAMP) can be conducted directly within a paper 
membrane 70-72, making the paper method suitable for nucleic 
acid extraction. Although the paper-based microfluidic chip has 
its unique advantages, it still needs to overcome the challenge 
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in NAAT such as reagent storage, and automation 55, 73. In 
addition, paper-based nucleic acid extraction is performed in an 
open environment and it is susceptible to contamination during 
the extraction process. Therefore, it is likely that a combination 
of paper extraction methods with microfluidics will overcome 
these challenges and broaden the scope of application for this 
cost-effective approach. 
2.4 Alternative nucleic acid purification methods based on 
microfluidics
In addition to the methods mentioned above, several simple 
and efficient nucleic acid extraction methods based on 
microfluidic systems have been developed for nucleic acid 
detection. These methods play a positive role in the 
development of microfluidic systems and increase the efficiency 
of nucleic acid extraction using microfluidics platforms. 
Appropriate processing and modification of existing materials 
could allow extraction of nucleic acids using simple and 
common materials, thereby making these approaches more 
accessible. Fu et al. used poly-diallyl-dimethylammonium-
chloride (PDDA), which has a large amount of positively charged 
quaternary ammonium groups, to modify the internal surface 
of a capillary making it able to attract negatively charged DNA 
or RNA 74. Organic solvents can also be applied to microfluidic 
systems for nucleic acid extraction. Morales et al. developed a 
dual inlet-dual output serpentine device that allows DNA 
isolation in the aqueous phases under stratified flow and 
droplet-based flow conditions 75. In a recent study, a novel 
microfluidic liquid phase nucleic acid purification chip was 
developed by Zhang et al. The chip was designed to selectively 
isolate DNA or RNA from low Copy/Single Bacterial Cells in the 
range of 5000 down to a single cell in a sample volume of 1 μL 
or 125 nL. The on-chip liquid phase nucleic acid purification was 
10-fold higher than the conventional column-based solid phase 
nucleic acid extraction methods with the added advantage of 
small volume handling capacity 76.
Application of microelectronic components to a microfluidic 
system has also been found to be effective in nucleic acid 
extraction. Marshall et al. proposed the use of integrated 
heaters in combination with isotachophoresis to lyse the 
sample and isolate nucleic acids 77. The authors used this system 
to process nucleic acids from clinically-derived blood samples. 
Han et al. invented a Self-powered switch-controlled system 
(SSNES) which has two disposable syringes and a switchgear 
made of polymethyl methacrylate (PMMA) blocks and an O-ring 
for the nucleic acid extraction. In this system, the authors use a 
dimethyl adipimidate (DMA)-based extraction method with the 
microfluidic system 78. Yoon et al. 79 also reported a DMA chip 
for RNA extraction from different cell lines with rapid processing 
time and high product purity (Fig. 5A).
Different chemicals that bind nucleic acids, can be applied to 
microfluidic systems for efficient nucleic acid extraction. Jin et 
al. incorporated dimethyl pimelimidate (DMP) into the 
microfluidic system which led to efficient extraction of nucleic 
acids (DNA and RNA) from various samples such as mammalian 
cells, bacterial cells, and viruses from human disease (Fig. 5B). 
The DMP captures the nucleic acid and the system does not 
need instruments or electricity 20. Since plasma is an important 
sample source for clinical testing, Liu et al. proposed a simple 
and highly efficient plasma separator that does not need 
centrifugation. Compared with other POC methods, this 
separator has higher DNA recovery efficiency, reaching up to 
84.5% 80. Adjusting the properties of the material and the 
charge of the nucleic acid allows for a greater range of isolation 
methods to be integrated with microfluidic platforms. Although 
the methods mentioned above apply different principles for 
nucleic acid extraction using microfluidic systems with unique 
advantages, their efficiency, affordability, security, and 
simplicity need to be further optimized for broader application 
and accessibility. A key area that need to be improved is the 
integration of nucleic acid extraction with downstream 
reactions. Several integration approaches have been identified 
to date that can contribute to POC and increased treatment 
efficiency 81-84, but opportunities remain to build on these 
technologies. Regardless of the isolation method utilized, 
certain measures should be taken to prevent nucleic acid 
contamination and ensure accuracy of the results and quality of 
the product.
3. Nucleic acid amplification using microfluidics approaches
Microfluidics-based approaches provide an ideal platform for 
nucleic acid amplification and rely mainly on fast prototyping by 
soft lithography in Polydimethylsiloxane (PDMS) or glass 
etching 85, 86. Although PDMS has been applied in many studies, 
the issue of evaporation limits its practical application due to 
gas permeability. In addition to this, injection molding87, 88, 
thermal bonding and hot embossing89, 90 along with changes in 
solvent use 91-93 are important alternatives which can improve 
nucleic acid amplification on a microfluidics system. Nucleic acid 
amplification on chips also confers the advantages of 
amplification speed, detection limit, sample demand, and 
detection accuracy 42, 94. In recent years, many kinds of nucleic 
acid amplification approaches such as PCR and isothermal 
amplification have been performed on the microfluidic system, 
with the achievement of fast and accurate detection. This 
section will summarize several promising techniques which 
have been used on microfluidic systems.
3.1 Digital PCR (dPCR) amplification of nucleic acids
qPCR technology is used to quantify nucleic acids and is the gold 
standard for the diagnosis of infectious diseases 95-97. However, 
it is a relative quantification technique that relies on a standard 
curve or reference gene assessment to determine the amount 
of target nucleic acid. For low copy number target DNA, issues 
such as primer efficiency and differences in template 
concentrations can markedly affect the detection sensitivity 
and accuracy at the end-stage 18, 19, 98, 99. dPCR is a third 
generation PCR technology which can provide a direct count of 
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target molecules without relying on any calibrators or external 
standards to determine the absolute number of molecules as 
low as a single copy 66. The concept behind digital PCR was first 
proposed by Sykes et al in 1992 100. Although this method was 
not referred to as "digital PCR" at the time, the basic 
experimental procedure for digital PCR was established. 
Moreover, the fundamental principle of digital PCR detection 
provided an all-or-none for the assay 101. In 1999, Vogelstein 
and Kinzler performed dPCR reactions using microplates for the 
first time, which allowed for a high throughput strategy 102. This 
approach allows for large-scale multiple dilution and liquid 
separation until the number of molecules to be detected does 
not exceed 1 (0 or 1) in each subdivided sample. All subdivided 
samples were subjected to PCR amplification under the same 
conditions, and the target molecules are amplified to generate 
a very strong fluorescence source. The number of samples and 
total number of microwells are counted and the Poisson 
distribution is used to predict the initial concentration of the 
target sequence 103, 104. dPCR can be further divided into droplet 
digital PCR (ddPCR) and integrated flow circuit (IFC) chip dPCR. 
Studies have demonstrated that ddPCR and IFC dPCR are more 
robust than standard qPCR approaches for detecting trace 
samples 101, 105, 106 and have been applied in gene mutation 
analysis 47, 107, prenatal diagnosis of chromosome abnormality 
46, 108, DNA copy number determination 50, 107, pathogen 
detection 78, 109, transgenic detection 55, 68, among other 
applications. Modifications to dPCR chip have been developed 
in recent years that have advanced the application of this 
innovative approach for detection and quantification of nucleic 
acids. Microfluidic technology in combination with dPCR offers 
greater throughput, high sensitivity, and improved accuracy 
over more traditional PCR-based methods.
Researchers have broken through many technical bottlenecks 
with the development of Micro-Electro-Mechanical System 
(MEMS) and microfluidic technology 73. Hansen’s group 
developed an ultra-high density megapixel digital PCR chip with 
1 million cells. The chip can have a density of up to 440,000 
reactors per square centimeter and a reaction chamber size of 
20 μm×20 μm×25 μm, which offers a dynamic range of 107 65. 
Shen et al. 110 established a slipchip consisting of two glass 
sheets, one etched with a reaction cell and the other linked to a 
channel. When the two lamellae are combined with the 
channel, a continuous flow path is formed, and the reaction 
reagent can enter the reaction chamber from the inlet to reach 
the outlet. When the two chips slide, the channels and the 
ridges are misaligned and the flow path is cut off. In recent 
years, our group developed an integrated temporary negative 
pressure-assisted microfluidic chip to combine DNA isolation 
and digital PCR detection in one chip. This research laid the 
foundation for the connection between different functional 
areas 111. Our team has developed a series of self-priming, 
liquid-divided, integrated flow path chips. An integrated on-
chip, valve-free and power-free microfluidic dPCR device has 
been developed based on a novel self-priming 
compartmentalization for the first time 112. In 2017, our team 
reported a dPCR chip with a scalable branch network structure 
(Fig. 6). The chip is a fully-encapsulated dPCR chip that has no 
waste or cross-contamination from the external environment. 
In addition, a negative pressure liquid separation method has 
been adopted in which the uniform dispersion of the sample 
can be accomplished without the aid of an external device. This 
method is more flexible and is suitable for rapid isolation113. 
Ning et al. 114 proposed a digital PCR chip with zero-water-loss. 
In this low-cost chip, the authors integrated a void in the space 
beneath the microwells, which provided power and water 
storage during the isolation procedure. 
In recent years, several techniques and instruments based on 
digital drop PCR (ddPCR) have been developed. Compared to 
microarray chips, the processing of ddPCR chips is simpler and 
the number of droplets is more flexible than in previous 
iterations of the technology 72, 115. Chen et al. reported a 
capillary-based droplet dPCR chip, which integrates droplet 
generation, PCR reaction, and flow detection in a single system. 
This approach avoids the fusion of droplets in the reaction 
chamber and sample loss caused by transfer between 
instruments 116. An ideal ddPCR assay should be easy and fast to 
operate in most laboratories. Huang et al. developed an off-chip 
monodispersion droplet generation method that can efficiently 
produce results without an emulsion step using a highly precise 
micro-channel array and a bench-top centrifuge machine. The 
results were robust and the cost of dPCR was reduced, 
supporting the idea that dPCR could be adopted in standard 
molecular laboratories 117.
Compared to traditional quantitative PCR techniques, dPCR 
achieves absolute quantification by measuring the copy number 
of a specific gene. However, dPCR cannot be used, at this time, 
to perform large-scale gene sequencing and can only be used 
for quantitative detection of specific known genes. Multiplex 
PCR detection is likely to be an attractive development direction 
for this technology and will promote the application of dPCR in 
mutation analysis 96 and genotyping 105, for example. In 
combination with different fluorescent probes or different 
intensities of fluorescence, dPCR can be applied in multiple 
detection systems 105, 118-120. Didelot et al. 121 used a multiplex 
picoliter droplet–based digital PCR method to detect human 
genomic DNA samples of 4 lengths (78, 159, 197, and 550 bp) 
and the results were consistent with the sequencing data run in 
parallel. Zhong et al. 122 reported a novel and easy method 
which is based on the singular nature of amplifications at 
terminal dilution for multiplexing dPCR in picolitre droplets. The 
authors theoretically performed 10 multiple detections by this 
approach. To achieve these results, they used 5 multiple 
detection assays for spinal muscular atrophy with just two 
fluorophores. 
In addition, it is worth mentioning that the detection method of 
digital PCR results mainly relies on the quality and intensity of 
the fluorescent signals (fluorescent dyes and probes) which can 
increase the cost of digital PCR and limit its application in POC 
diagnosis. Therefore, it is necessary to develop low cost 
detection devices or other signal readout methods to promote 
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its wider application. The technology of dPCR is rapidly growing 
and its performance in different fields is expected to eventually 
outperform qPCR.  The Minimum Information for Publication of 
Quantitative Real-Time PCR Experiments (MIQE) Guidelines for 
dPCR were proposed by Huggett et al 123. Similar to the MIQE 
for qPCR 124, the MIQE for dPCR will help to standardize 
experimental protocols, maximize efficient utilization of 
resources, and enhance the impact of this promising new 
technology.
3.2 Isothermal Quantification of nucleic acids
Since qPCR requires a thermocycler and a 2-3 hour amplification 
time, it is not suitable for POC in all cases. Given the 
developments of nucleic acid amplification technology in recent 
years, nucleic acid isothermal amplification technology has 
been increasingly applied in POC systems. The nucleic acid 
isothermal amplification technology does not require different 
temperature cycles to generate new product from the nucleic 
acid template. It does not depend on sophisticated equipment 
and has shown good application prospects in POC. Among the 
isothermal amplification techniques, Loop-mediated isothermal 
amplification (LAMP) has relatively wider application than other 
technologies. Recombinase Polymerase Amplification (RPA) is a 
nucleic acid detection technology that has also shown broad 
application prospects 125-127. Both approaches offer alternatives 
for nucleic acid amplification that may be amenable for use in 
POC. 
3.2.1 LAMP-based quantification of nucleic acids
The principle of Loop-mediated isothermal amplification (LAMP) 
is that at a temperature of 65°C, DNA is synthesized constantly 
and self-recycling is facilitated using 4 primers (2 external 
primers and 2 internal primers) and a DNA polymerase (Bst DNA 
polymerase) that lacks a 3’ to 5’ exonuclease proofreading 
capability 128. Compared with dPCR, dLAMP has a shorter 
reaction time and better anti-inhibitory capacity, which points 
to the rapidity and reliability of the method for use in POC 129, 
130. To meet the needs of on-site testing, it is necessary to pre-
embed reaction reagents into the chip. Ma et al. developed a 
self-driven microfluidic method by creating hydrophilic PDMS 
surfaces that allow for digital LAMP. The surfaces remain stable 
for 6 months after dry storage without major loss of efficiency 
131. The detection process takes 30 minutes and the technique 
can identify as few as 11 copies of a specific target gene in the 
genome. dLAMP integrates well with different droplet 
generation methods. A Droplet Digital Detection (IC 3D) system 
was proposed by Zhang et al 132. The system generates droplets, 
‘microreactors’, that are incubated at an isothermal 
temperature for several minutes to generate a fluorescence 
signal which indicates the formation of the product. Hu et al. 
invented a method to rapidly and continuously generate a large 
number of microliter droplets up to nanoliter volume and 
applied it in digital LAMP for rapid quantitative detection of H5 
Subtype Avian Influenza Virus. This method utilizes the 
interfacial tension between the oil and air. As a result, the 
authors were able to demonstrate that dLAMP had a 
comparable sensitivity and detection efficiency to qPCR and 
dPCR129. In 2018, a study by Chiu improved on this digital LAMP 
self-digitization (SD) chip 133 and proposed a new SD chip for 
digital LAMP to detect HPV-18 gene with higher efficiency 134.
In many cases, only the presence or absence of target is 
required in POC. Therefore, the application of LAMP in POC 
does not necessarily require absolute quantification. Yuan et al. 
developed a disc chip using colorimetric LAMP for the detection 
of peanut, sesame and soybean allergens. The authors found 
that the detection limit was as low as 0.4 ng/μL130. An 
automated approach using the lab-on-a-disc and a miniaturized 
rotary instrument equipped with three heating blocks was 
developed by Oh et al 135. The authors demonstrated that a milk 
sample contaminated with foodborne pathogens could be 
automatically run on the centrifugal disc by LAMP with a 
detection level as low as 10 bacteria within 65 minutes. A LAMP-
based approach using on-capillary array technology was 
developed by Ning et al 136. This microarray performs 
hydrophobic processing on capillaries and immobilizes primers 
into capillaries via chitosan to process LAMP with a detection 
sensitivity as low as 50 copies/capillary. Trinh et al. 137  have 
designed a multiplex LAMP plastic microdevice chip that is eco-
friendly, and can rapidly detect four pathogens within a 
concentration range of 0.12-0.13 ng/μL. 
Since the amplification product of LAMP contains large amounts 
of pyrophosphate in addition to the double-stranded nucleic 
acid, the signal readout of LAMP is more flexible than that of 
traditional PCR. In recent years, fluorescence signals138, 139, 
electrochemical signals140, 141, and visual detection142, 143 
readout methods have been applied successfully to microfluidic 
platforms to promote the application of LAMP in pathogen 
detection and clinical diagnosis. The microfluidic-based LAMP is 
effective in achieving rapid results and miniaturized detection. 
However, due to the LAMP reaction conditions, further efforts 
are required to improve detection specificity, primer design, 
and temperature control for optimization of LAMP. Moreover, 
chip designs that implement multiple target detection on one 
chip would be of significant value and need to be developed.  
3.2.2 RPA-based quantification of nucleic acids
RPA requires a recombinase capable of binding single-stranded 
nucleic acids (oligonucleotide primers), a single-stranded DNA 
binding protein (SSB), and a strand displacement DNA 
polymerase which is active at room temperature, and an 
optimal temperature at 37℃ 119. The first step in this process is 
the formation of a complex between the recombinase and the 
primer. This complex binds to complementary DNA of the 
homologous sequence in the double-stranded DNA. Once the 
primers are bound to the homologous sequences, a chain 
exchange reaction occurs to initiate DNA synthesis and 
exponentially amplify the target region on the template. The 
replaced DNA strand binds to SSB to prevent further 
substitution. In this system, a synthetic event is initiated by two 
opposing primers and the whole process is completed within 10 
minutes. This approach offers a faster amplification method 
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than PCR or LAMP．Moreover, there is no evaporation problem 
due to the relatively low reaction temperature 126, 144. 
In recent years, several researchers have adopted this approach 
to incorporate microfluidics in order to improve on the rapidity 
and accuracy of RPA 125, 127, 145. Li et al. designed a Picoliter Well 
Array Chip for dRPA which could function at 39℃ in 20 minutes 
26. The chip has 27,000 picoliter wells (314 pL) and cross-
contamination between microwells is avoided through 
silanization modification by methoxy-PEG-silane. Schuler et al. 
25 performed a digital droplet RPA by the centrifugal step 
emulsification method in order to detect Listeria 
monocytogenes DNA. Shen et al. 23 developed a digital RPA Slip 
Chip, which can be used for absolute quantification of target 
nucleic acid molecules. Multiple RPA-based detections can also 
be implemented on a microfluidic platform as demonstrated 
recently by Song et al146. The authors designed a high-level 
multiplexing microfluidics chip dubbed rapid amplification 
(RAMP), which consists of a first-stage RPA and second-stage 
LAMP. The approach was rapid, requiring only 40 minutes, and 
provided high sensitivity and specificity for target detection. 
Kersting et al. developed an on-chip multiplex RPA approach 
which is performed in a programmable hybridization chamber 
and can detect 10 CFU of methicillin-resistant Staphylococcus 
aureus and Salmonella enterica and 100 CFU for Neisseria 
gonorrhoeae in <20 minutes147. Choi et al. described a direct 
RPA strategy on a disc chip. This strategy can simultaneously 
detect Salmonella enterica, Escherichia coli O157:H7, and Vibrio 
parahaemolyticus in 30 minutes from milk samples without 
DNA extraction 94. Chen et al. 24 also developed a disc RPA chip 
which can simultaneously detect five distinct pathogens from 
urine samples within 40 minutes. Because RPA has a unique 
amplification principle and does not require a cycle 
temperature similar to PCR, the RPA can be combined with 
other technologies to achieve rapid detection on microfluidics. 
A new technique for isothermal solid-state 
amplification/detection (ISAD) was proposed to rapidly detect 
single point mutations in cancer 148. This is a label-free, real-
time detection technique that combines RPA with a solid-phase 
amplification based on silicon microrings. In this study, ISAD was 
used to detect single mutations in the Harvey RAS gene, and this 
approach yielded an amplification product efficiency 100-times 
greater than that of RPA and conventional PCR methods, alone,  
in terms of sensitivity. To detect RPA amplification products, 
real-time fluorescent detection94, 149 or lateral flow detection150, 
151 are mainly used on the microfluidics system. Additional 
product detection methods should be developed to promote 
the application of RPA. In recent years, RPA technology based 
on microfluidics has witnessed rapid advancements. To increase 
accessibility of this technique, the production cost of the chip 
and the reaction cost of the RPA should be reduced. Moreover, 
due to the high sensitivity of RPA, one of the limitations for its 
use is related to non-specific product amplification and 
contamination. These latter concerns should be considered 
with regard to the use of RPA in combination with microfluidic 
platforms. Further optimization of primers and probe 
sequences for different genes will increase the feasibility of 
using RPA-based microfluidic approaches in POC systems.
4. INEAD system and clinical application
4.1 INEAD systems
The integration of sample preparation and amplification on a 
microfluidics chip system can prevent contamination, reduce 
sample loss, and reduce detection time. Thus, the INEAD system 
has the potential to produce more accurate and robust 
detection results with reduced time cost. Over the years, 
various strategies have been tested to optimize integration and 
automation of the INEAD system and this section introduces 
some approaches for implementing the INEAD system.
The centrifugal microfluidic chip could pre-embed the reagents 
required for the extraction and amplification processes on a CD-
shaped chip. The centrifugal force serves as the driving force for 
the liquid flow 41, 152, 153. Jung et al. 154 developed a microfluidic 
chip integrated with RNA extraction and RT-LAMP to extract 
influenza virus RNA. The chip contains four reservoirs: a viral 
RNA sample pool, a wash solution pool, an eluent pool, and an 
RT-LAMP reagent pool. It also contains two chambers: the 
waste reservoir and the RT-LAMP reaction chamber. By 
controlling the rotational speed of the chip, viral RNA samples, 
washings, eluents, and RT-LAMP reagents are sequentially 
passed through the microbeads by different centrifugal forces 
to control adsorption and subsequent washing and elution of 
nucleic acid product. Loo et al. 152 introduced a centrifugal chip 
integrating DNA extraction and LAMP that can be used to 
quantify the number of target bacteria by fluorescence intensity 
from only a small amount of body fluid sample (Fig.7B). Zhang 
et al. 155 reported a disc chip in which the nucleic acid 
purification was integrated with the LAMP approach. The chip 
can be used to detect six kinds of pathogens simultaneously in 
an electricity-free manner. This latter feature demonstrates 
that this approach may have great potential for application in 
POC systems. As a simple way to achieve integration, in recent 
years, many studies have been based on centrifugal force 24, 156-
158 and commercial applications have been implemented that 
point to this technique as having increasingly broad application.
Paper microfluidics is another ideal platform for integration 
which could process the fluid in the reaction by introducing 
buffers, samples and reagents. Connelly et al. 53 developed an 
integrated system containing sample preparation and LAMP 
(Fig. 7A). The paper-based chip has a multi-layered structure 
and slides in and out of the paper chip to introduce a sample 
and a reaction reagent. Finally, LAMP's endpoint detection is 
simplified through use of a handheld UV power and camera. 
While this will reduce the automation aspect of this particular 
approach, it will allow for a low tech option in cases where POC 
sites have limited technical resources. Tang et al. also designed 
an integrated paper-based system in which the authors used a 
sponge-based reservoir and a paper-based valve for nucleic acid 
extraction. The subsequent isothermal reaction was achieved 
with micro-heated components and pre-embedded reagents. 
The system could detect Salmonella typhimurium in food 
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samples within 1 h with a detection limit as low as 10-2~10-3 
bacteria 60. 
Capillaries are also an effective tool for integration in many 
nucleic acid purification and amplification approaches. Liu et al. 
159 developed an excellent approach for integrating capillary-
array microsystems that includes a heating block, a 
multichannel syringe pump, a bidirectional magnetic force 
controller, and a fluorescence detection module (Fig. 7C). In this 
system, DNA extraction and LAMP products detection were in 
the capillary-array with the capacity to process 10 samples 
simultaneously. Fu et al. also reported an integrated capillary 
system which could allow on-site qPCR 74. In this method, 
nucleic acid extraction was achieved through a PDDA modified 
capillary followed by temperature control of the PCR through 
water circulation pumps. This system achieved the steps 
(including extraction, amplification, and detection) within 40 
minutes.
Some industries have launched fully automated nucleic acid 
diagnostic products such as GeneXpert®, Filmarray ®, and Atlas 
Genetics io®.GeneXpert is a fully automated molecular 
diagnostics platform developed by CepheidTM. The GeneXpert 
reduces user handling of samples by integrating sample 
preparation steps with PCR amplification and real-time 
fluorescence detection in the same cartridge. This is a closed 
system that relies on valve actuation and hydraulic control. The 
PCR process is fully automated, with simple operation and fast 
results. The Cartridge of GeneXpert is used for quantitative 
detection of multiple samples. Since it involves nucleic acid 
extraction, amplification, and monitoring, the cartridge 
structure is complex and costly. Filmarray is a fully automated 
molecular diagnostics platform based on microfluidic 
technology that provides qualitative target detection and is 
developed by BioFireTM. This approach utilizes a test strip that 
contains all reagents needed for nucleic acid extraction and 
amplification. The product uses multiplex PCR analysis 
technology to perform the detection of up to 24 targets at a 
time on the same sample within an hour and is ideally suited for 
early rapid screening of multiple infectious diseases. Atlas 
Genetics is a microfluidic-based POC product developed by 
Atlas GeneticsTM. Considering that electrochemical detection is 
employed in this product, no complicated optics are needed in 
the instrument, and the instrument could be miniaturized for 
portability making it ideal for POC sites. In 2016, Bohui 
CompanyTM successfully developed a fully automatic 
genotyping detection chip for Human Papilloma Virus (HPV) 
that integrates sample processing, nucleic acid amplification 
and multiple interpretations. One major advantage for this 
technology is the rapidity since only 2 minutes are required to 
complete sample processing and detection. The detection 
requires a chip controller only, which contributes to the 
automation of the whole process from nucleic acid extraction, 
PCR amplification, reverse hybridization to results 
interpretation. Another advantage of this approach is that the 
entire experiment can be conducted in a sealed chip, which not 
only avoids DNA contamination, but also eliminates human 
error introduced by manual operation. 
The integrated microfluidic POC system has been flourishing as 
a means to conduct fast, accurate nucleic acid detection. These 
systems are often pre-packaged, with a predetermined reagent 
solution in the chip or with the reagent in the reservoir. Indeed, 
nucleic acid extraction coupled with “in situ PCR” has been 
found to have great application in INEAD 63. However, there are 
not many researches on digital nucleic acid detection integrated 
with sample preparation to achieve “sample-in-digital-answer 
out (SIDAO)”. Based on the air permeability of PDMS, a 
microfluidic chip which used the negative pressure provided by 
a syringe to achieve sample injection and enable digital PCR 
reactions was developed. The systems were successful in 
isolating and amplifying nucleic acid from a tissue source 111. 
This approach is convenient and rapid, cost-effective, accurate, 
and suitable for use in a standard molecular laboratory. Yang et 
al 160 also reported a system that integrated the DNA extraction 
and digital RPA (Fig 7D).The system had an automated module 
to allow liquid transfer and the reaction buffer was injected into 
the digital RPA chip through the mechanical pressure. Using this 
system, they successfully performed absolute quantification of 
a Mycobacterium tuberculosis gene from saliva and serum.
4.2 Clinical application of the INEAD system
As medical care advances, the demand for cost-effective, rapid 
and accurate nucleic acid detection has pushed technological 
advances that promote the application of INEAD system in 
clinical practice. Many commercial INEAD systems have been 
clinically applied in point-of-care testing (POCT) of tuberculosis 
161, 162, HIV163, Methicillin-resistant Staphylococcus aureus164, 
and Chlamydia trachomatis165. The INEAD approaches used 
were found to give accurate results in a short time frame, which 
helped to promote medical development and support in remote 
areas. Indeed, some of the approaches have been endorsed by 
the World Health Organization (WHO) 166. In a recent study, Xin 
et al 156 test for the presence of the rotavirus A from 48 clinical 
stool samples using the INEAD system and found that the 
sensitivity and specificity were both 100%. Wang et al 167 
detected the S. pneumoniae and M. pneumoniae from 63 
clinical specimens (oropharyngeal swabs and bronchoalveolar 
lavage fluid), which further supported the value of using INEAD 
systems for the analysis of clinical specimens. The clinical 
application value of the INEAD system was also demonstrated 
by Choi et al., in the positive test of 16 HBV- clinical samples168. 
While quite a bit of recent progress has been made, it is 
important to recognize the value of further research involving 
INEAD-based approaches for accurate, rapid detection of virus, 
pathogen, or immunogen in patient samples.
5. Summary and Conclusions
In the current review, the history and development of the 
microfluidics field was captured to provide an assessment of 
past and current techniques in terms of accuracy, reliability, 
cost and speed, particularly in the context of POC. Further, this 
study offered the current perspective on the state of this field 
in terms of areas for future growth and technological 
advancement. This work compared methods for nucleic acid 
extraction on microfluidic systems, methods for nucleic acid 
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amplification, and integrated microfluidic chips for sample 
preparation combined with nucleic acid amplification.
In terms of sample preparation, this study offered insight into 
the different nucleic acid extraction methods based on 
magnetic beads, silicon-based materials, and paper-based 
materials, in the context of their use with microfluidics. The 
magnetic beads method is characterized by controllability and 
high flux along with simple and fast procedures. Silicon material 
is especially suitable for SPE. Paper-based nucleic acid 
extraction is characterized by low cost and rapid completion 
time, offering several advantages over other methodologies. 
Meanwhile, there are many different ways to achieve nucleic 
acid extraction, many of which can be integrated with 
microfluidics for optimal outcome. The choice of nucleic acid 
extraction method determines the methods of integration with 
downstream nucleic acid amplification and the speed of 
detection for the entire process, which are crucial parts of 
nucleic acid detection.
For nucleic acid amplification methods on microfluidic systems, 
this study introduced dPCR, LAMP and RPA methods which are 
currently widely used and have high potential for POC 
application. dPCR, as the current mainstream nucleic acid 
amplification method, is suitable for microfluidic systems due to 
its technical maturity given that 20 years have passed since it 
was first proposed. The application of this technology to 
microfluidic systems requires less reaction completion time and 
results in higher sensitivity. LAMP-based instruments are 
simpler, cheaper, and consume less energy during the heating 
steps. However, RPA is the only current nucleic acid 
amplification technology that can rapidly react at room 
temperature. In the microfluidic system, the analysis 
performance, throughput, detection accuracy and dynamic 
range of the digital nucleic acid amplification should be further 
explored.
6. Future Outlook
The microfluidic chip revolutionized and integrated the process 
of nucleic acid extraction, amplification, and detection but 
many challenges are yet to be resolved. For sample preparation, 
recent technology allows for the extraction of nucleic acids on 
the microfluidic system from simple samples but cannot readily 
handle more complex samples such as bone, animal and plant 
tissue. Therefore, handling complex samples on microfluidic 
systems is still an urgent problem. Moreover, the complete 
encapsulation of nucleic acid extraction will be a particularly 
effective advancement to prevent nucleic acid contamination 
during processing. In addition, the challenge of optimal 
integration of the sample preparation with digital nucleic acid 
amplification to achieve SIDAO needs further exploration. 
Further development of INEAD systems using the microfluidic 
chip will help us to realize more accessible “sample-in-answer-
out” to improve rapid and accurate test results in POC. However, 
the velocity, reliability, accuracy and cost of the integrated 
systems will continue to be key hurdles to progress and broad 
use of these technologies in POC.
Moving forward, for better service in POC and clinical 
application, any commercialized integrated system should also 
be miniaturized and affordable. Although there are presently 
many products, the cost is high and presents a barrier for broad 
accessibility to some economically disadvantaged and rural 
areas. To make nucleic acid extraction-microfluidics an integral 
part of rural or emergency care, POC will require a significant 
improvement in costs associated with the sample prep and 
technology. In future, the application of INEAD systems for POC 
must have the characteristics of automation, low cost, 
versatility and miniaturization. It would also be important to 
have a visualized data output module and information 
transmission module to allow for improved communication of 
results between POC and potential clinical partners at more 
metropolitan hubs. Therefore, future POC personnel would not 
need specialized, operational training beyond careful sample 
collection and basic instrument handling. In addition, for most 
rural and remote areas, lack of resources and economical 
constraints remain limiting factors. In the future, the application 
of the INEAD system to mobile detection vehicles will enable 
them to serve more people in the medical and food safety fields, 
which will promote the application of POC systems. This puts 
higher requirements on the stability, operability, and energy 
requirements for any system developed. In many medical fields, 
accurate test results are required and SIDAO is an ideal testing 
process leading to improved sample preparation and nucleic 
acid detection technologies. It is our hope that this review will 
encourage further dialogue and exploration towards the 
development of microfluidic systems for NAAT integration. It is 
anticipated that future research will provide further integrative 
solutions for improving POC and establishing broader 
accessibility for microfluidics-based technology across clinical 
applications.
Conflicts of interest
The authors declare that there are no conflicts of interest associated 
with the current work.
Acknowledgements 
The authors are grateful for the financial support from the 
National Key R&D Program of China (2018YFF01012100), the 
Open Research Project of the State Key Laboratory of Industrial 
Control Technology, Zhejiang University, China (No. 
ICT1900327) and the Fundamental Research Funds for the 
Central Universities. JXZ and DCD are supported by grants from 
the National Science Foundation, USA (CHE 0947043) and the 
National Institutes of Health, USA (COBRE-4020GM104360-04, 
Vaughan, R. as PI), respectively.
Notes and references
1. G. Mtove, B. Nadjm, I. C. E. Hendriksen, B. Amos, F. 
Muro, J. Todd and H. Reyburn, Clinical Infectious 
Diseases, 2011, 53, 548-554.
2. E. Lencova, Z. Broukal and J. Spizek, Folia 
Microbiologica, 2010, 55, 559-568.
3. J. D. Tucker, C. H. Bien and R. W. Peeling, Current 
Page 9 of 21 Lab on a Chip
ARTICLE Journal Name
10 | J. Name., 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
Opinion In Infectious Diseases, 2013, 26, 73-79.
4. F. Tinajeros, D. Grossman, K. Richmond, M. Steele, S. 
G. Garcia, L. Zegarra and R. Revollo, Sexually 
Transmitted Infections, 2006, 82, V17-V21.
5. N. Ravi, G. Rizzi, S. E. Chang, P. Cheung, P. J. Utz and 
S. X. Wang, Biosensors and Bioelectronics, 2019, 130, 
338-343.
6. M. Book, L. E. Lehrmann, X. Zhang and F. Stueber, 
Anasthesiologie Intensivmedizin Notfallmedizin 
Schmerztherapie, 2010, 45, 732-738.
7. N. K. Tran, Z. Godwin and J. Bockhold, Point of care, 
2012, 11, 180-183.
8. N. P. Pai, C. Vadnais, C. Denkinger, N. Engel and M. 
Pai, Plos Medicine, 2012, 9.
9. A. Manz, N. Graber and H. M. Widmer, Sensors And 
Actuators B-Chemical, 1990, 1, 244-248.
10. L. Gervais, R. N. De and E. Delamarche, Advanced 
Materials, 2011, 23, 151-176.
11. V. Gubala, L. F. Harris, A. J. Ricco, M. X. Tan and D. E. 
Williams, Analytical chemistry, 2012, 84, 487.
12. W. J. Lu, Y. P. Chen, Z. Liu, W. B. Tang, Q. Feng, J. S. 
Sun and X. Y. Jiang, Acs Nano, 2016, 10, 6685-6692.
13. P. Toren, E. Ozgur and M. Bayindir, Lab on a Chip, 
2016, 16, 2572-2595.
14. L. Ninove, A. Nougairede, C. Gazin, C. Zandotti, M. 
Drancourt, X. de Lamballerie and R. N. Charrel, 
Journal Of Clinical Virology, 2010, 49, 304-305.
15. C. K. Y. Ng, G. G. D. Costanzo, L. M. Terracciano and 
S. Piscuoglio, Frontiers in Medicine, 2018, 5, 78-.
16. K. C. Chan and Y. M. Lo, Histology & Histopathology, 
2002, 17, 937-943.
17. J. C. Tsang and Y. M. Lo, Pathology, 2007, 39, 197-207.
18. C. A. Holland and F. L. Kiechle, Current opinion in 
microbiology, 2005, 8, 504-509.
19. L. Magro, C. Escadafal, P. Garneret, B. Jacquelin, A. 
Kwasiborski, J. C. Manuguerra, F. Monti, A. 
Sakuntabhai, J. Vanhomwegen and P. Lafaye, Lab on 
A Chip, 2017, 17.
20. C. E. Jin, T. Y. Lee, B. Koo, K. C. Choi, S. Chang, S. Y. 
Park, J. Y. Kim, S. H. Kim and Y. Shin, Analytical 
chemistry, 2017, 89, 7502-7510.
21. L. Zhang, B. Ding, Q. Chen, Q. Feng, L. Lin and J. Sun, 
TrAC Trends in Analytical Chemistry, 2017, 94, 106-
116.
22. I. H. K. Basha, E. T. Ho, C. M. Yousuff and N. H. Bin 
Hamid, Micromachines, 2017, 8.
23. F. Shen, E. K. Davydova, W. Du, J. E. Kreutz, O. 
Piepenburg and R. F. Ismagilov, Analytical chemistry, 
2011, 83, 3533-3540.
24. J. Chen, Y. Xu, H. Yan, Y. Zhu, L. Wang, Y. Zhang, Y. Lu 
and W. Xing, Lab on a Chip, 2018, 18, 2441-2452.
25. F. Schuler, F. Schwemmer, M. Trotter, S. Wadle, R. 
Zengerle, F. von Stetten and N. Paust, Lab on a Chip, 
2015, 15, 2759-2766.
26. Z. Li, Y. Liu, Q. Wei, Y. Liu, W. Liu, X. Zhang and Y. Yu, 
PLoS One, 2016, 11, e0153359.
27. Y. Zhang and N.-T. Nguyen, Lab on a Chip, 2017, 17, 
994-1008.
28. T. Gou, J. Hu, W. Wu, X. Ding, S. Zhou, W. Fang and Y. 
Mu, Biosensors & bioelectronics, 2018, 120, 144-152.
29. T. Tangchaikeeree, D. Polpanich, A. Elaissari and K. 
Jangpatarapongsa, Colloids and Surfaces B: 
Biointerfaces, 2017, 158, 1-8.
30. V. Kamat, S. Pandey, K. Paknikar and D. Bodas, 
Biosensors & bioelectronics, 2018, 99, 62-69.
31. L. Zhang, R. N. Deraney and A. Tripathi, 
Biomicrofluidics, 2015, 9.
32. R.-Q. Zhang, S.-L. Hong, C.-Y. Wen, D.-W. Pang and Z.-
L. Zhang, Biosensors & bioelectronics, 2018, 100, 348-
354.
33. J.-C. Yu, C.-C. Hu, W.-H. Chang, P.-C. Chen, M. S. Lee, 
K.-T. Peng and G.-B. Lee, Microfluidics And 
Nanofluidics, 2018, 22.
34. X. Shi, C.-H. Chen, W. Gao, S.-h. Chao and D. R. 
Meldrum, Lab on a Chip, 2015, 15, 1059-1065.
35. U. Lehmann, C. Vandevyver, V. K. Parashar and M. A. 
Gijs, Angewandte Chemie International Edition, 2006, 
45, 3062-3067.
36. S. M. Berry, E. T. Alarid and D. J. Beebe, Lab on a chip, 
2011, 11, 1747-1753.
37. K.-Y. Lien, W.-C. Lee, H.-Y. Lei and G.-B. Lee, 
Biosensors and Bioelectronics, 2007, 22, 1739-1748.
38. O. Mosley, L. Melling, M. D. Tarn, C. Kemp, M. M. 
Esfahani, N. Pamme and K. J. Shaw, Lab on a Chip, 
2016, 16, 2108-2115.
39. B. Shu, Z. Li, X. Yang, F. Xiao, D. Lin, X. Lei, B. Xu and 
D. Liu, Chem Commun (Camb), 2018, 54, 2232-2235.
40. N. C. Cady, S. Stelick and C. A. Batt, Biosensors & 
bioelectronics, 2004, 19, 59-66.
41. T.-H. Kim, J. Park, C.-J. Kim and Y.-K. Cho, Analytical 
chemistry, 2014, 86, 3841-3848.
42. B. Bruijns, A. van Asten, R. Tiggelaar and H. 
Gardeniers, Biosensors-Basel, 2016, 6.
43. C. W. Price, D. C. Leslie and J. P. Landers, Lab Chip, 
2009, 9, 2484-2494.
44. T. Gou, J. Hu, W. Wu, X. Ding, S. Zhou, W. Fang and Y. 
Mu, Biosensors and Bioelectronics, 2018, 120, 144-
152.
45. N. C. Cady, S. Stelick and C. A. Batt, Biosensors & 
bioelectronics, 2003, 19, 59-66.
46. L. A. Christel, K. Petersen, W. McMillan and M. A. 
Northrup, J Biomech Eng-T Asme, 1999, 121, 22-27.
47. Y. C. Chung, M. S. Jan, Y. C. Lin, J. H. Lin, W. C. Cheng 
and C. Y. Fan, Lab on a Chip, 2004, 4, 141-147.
48. B. H. Park, S. J. Oh, J. H. Jung, G. Choi, J. H. Seo, D. H. 
Kim, E. Y. Lee and T. S. Seo, Biosensors & 
bioelectronics, 2017, 91, 334-340.
49. L. Christel, K. Petersen, W. McMillan and M. 
Northrup, Journal of biomechanical engineering, 
1999, 121, 22-27.
50. J. Khandurina, S. C. Jacobson, L. C. Waters, R. S. Foote 
and J. M. Ramsey, Analytical chemistry, 1999, 71, 
Page 10 of 21Lab on a Chip
Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2019, 00, 1-3 | 11
Please do not adjust margins
Please do not adjust margins
1815-1819.
51. S. Petralia, E. L. Sciuto and S. Conoci, The Analyst, 
2017, 142, 140-146.
52. G. Gunal, C. Kip, S. E. Ogut, D. D. Usta, E. Senlik, G. 
Kibar and A. Tuncel, Mat Sci Eng C-Mater, 2017, 74, 
10-20.
53. J. T. Connelly, J. P. Rolland and G. M. Whitesides, 
Analytical chemistry, 2015, 87, 7595-7601.
54. A. K. Yetisen, M. S. Akram and C. R. Lowe, Lab on a 
Chip, 2013, 13, 2210-2251.
55. J. R. Choi, K. W. Yong, R. Tang, G. Yan, T. Wen, L. Fei, 
B. Pingguan-Murphy, B. Dan and X. Feng, Trac Trends 
in Analytical Chemistry, 2017, 93.
56. S. B. Boppana, S. A. Ross, Z. Novak, M. Shimamura, R. 
W. Tolan, A. L. Palmer, A. Ahmed, M. G. Michaels, P. 
J. Sánchez and D. I. Bernstein, Jama, 2010, 303, 1375-
1382.
57. D. Zhang, D. Broyles, E. A. Hunt, E. Dikici, S. Daunert 
and S. K. Deo, The Analyst, 2017, 142, 815-823.
58. L. Zhang, Y. Zhang, C. Wang, Q. Feng, F. Fan, G. Zhang, 
X. Kang, X. Qin, J. Sun, Y. Li and X. Jiang, Analytical 
chemistry, 2014, 86, 10461-10466.
59. W. Gan, B. Zhuang, P. Zhang, J. Han, C.-X. Li and P. 
Liu, Lab on a Chip, 2014, 14, 3719-3728.
60. R. Tang, H. Yang, Y. Gong, M. You, Z. Liu, J. R. Choi, T. 
Wen, Z. Qu, Q. Mei and F. Xu, Lab on a Chip, 2017, 
17, 1270-1279.
61. X. Ye, J. Xu, L. Lu, X. Li, X. Fang and J. Kong, Analytica 
chimica acta, 2018.
62. K. A. Hagan, C. R. Reedy, M. L. Uchimoto, D. Basu, D. 
A. Engel and J. P. Landers, Lab on a Chip, 2011, 11, 
957-961.
63. W. Gan, Y. Gu, J. Han, C. X. Li, J. Sun and P. Liu, 
Analytical chemistry, 2017, 89, 3568-3575.
64. S. A. Byrnes, J. D. Bishop, L. Lafleur, J. R. Buser, B. Lutz 
and P. Yager, Lab Chip, 2015, 15, 2647-2659.
65. N. M. Rodriguez, J. C. Linnes, A. Fan, C. K. Ellenson, N. 
R. Pollock and C. M. Klapperich, Analytical chemistry, 
2015, 87, 7872-7879.
66. Y. Zou, M. G. Mason, Y. Wang, E. Wee, C. Turni, P. J. 
Blackall, M. Trau and J. R. Botella, Plos Biology, 2017, 
15, 96-104.
67. A. V. Govindarajan, S. Ramachandran, G. D. Vigil, P. 
Yager and K. F. Böhringer, Lab on A Chip, 2011, 12, 
174-181.
68. J. C. Linnes, A. Fan, N. M. Rodriguez, B. Lemieux, H. 
Kong and C. M. Klapperich, Rsc Advances, 2014, 4, 
42245.
69. C. F. Fronczek, S. P. Tu, D. K. Harshman, A. M. Nicolini 
and J. Y. Yoon, Rsc Advances, 2014, 4, 11103-11110.
70. M. S. Cordray and R. R. Richards-Kortum, Malaria 
Journal, 2015, 14, 472.
71. M. M. Ali, S. D. Aguirre, Y. Xu, C. D. Filipe, R. Pelton 
and Y. Li, Chemical Communications, 2009, 45, 6640-
6642.
72. B. A. Rohrman and R. R. Richards-Kortum, Lab on A 
Chip, 2012, 12, 3082.
73. N. Kaur and B. J. Toley, The Analyst, 2018, 
10.1039.C1037AN01943B.
74. Y. Fu, X. Zhou and D. Xing, Lab on a Chip, 2017, 17, 
4334-4341.
75. M. C. Morales and J. D. Zahn, Microfluidics & 
Nanofluidics, 2010, 9, 1041-1049.
76. R. Zhang, H.-Q. Gong, X. Zeng, C. Lou and C. Sze, 
Analytical chemistry, 2013, 85, 1484-1491.
77. L. A. Marshall, L. L. Wu, S. Babikian, M. Bachman and 
J. G. Santiago, Analytical chemistry, 2012, 84, 9640-
9645.
78. K. Han, Y. J. Yoon, S. Yong and K. P. Mi, Lab on A Chip, 
2015, 16, 132-141.
79. J. Yoon, Y.-J. Yoon, T. Y. Lee, M. K. Park, J. Chung and 
Y. Shin, Sensors and Actuators B: Chemical, 2018, 255, 
1491-1499.
80. C. Liu, S.-C. Liao, J. Song, M. G. Mauk, X. Li, G. Wu, D. 
Ge, R. M. Greenberg, S. Yang and H. H. Bau, Lab on a 
Chip, 2016, 16, 553-560.
81. C. Liu, E. Geva, M. Mauk, X. Qiu, W. R. Abrams, D. 
Malamud, K. Curtis, S. M. Owen and H. H. Bau, The 
Analyst, 2011, 136, 2069-2076.
82. S.-C. Liao, J. Peng, M. G. Mauk, S. Awasthi, J. Song, H. 
Friedman, H. H. Bau and C. Liu, Sensors and Actuators 
B: Chemical, 2016, 229, 232-238.
83. J. Song, M. G. Mauk, B. A. Hackett, S. Cherry, H. H. 
Bau and C. Liu, Analytical chemistry, 2016, 88, 7289-
7294.
84. J. Song, C. Liu, M. G. Mauk, J. Peng, T. Schoenfeld and 
H. H. Bau, Analytical chemistry, 2017, 90, 1209-1216.
85. D. C. Duffy, S. Oja, G. M. Whitesides and J. C. 
Mcdonald, Analytical chemistry, 1998, 70, 4974-4984.
86. W. Du, L. Li, K. P. Nichols and R. F. Ismagilov, Lab on 
A Chip, 2009, 9, 2286-2292.
87. M. Ogura, Y. Agata, K. Watanabe, R. M. McCormick, 
Y. Hamaguchi, Y. Aso and M. Mitsuhashi, Clinical 
chemistry, 1998, 44, 2249-2255.
88. M. Geissler, J. A. Beauregard, I. Charlebois, S. Isabel, 
F. Normandin, B. Voisin, M. Boissinot, M. G. Bergeron 
and T. Veres, Engineering in Life Sciences, 2011, 11, 
174-181.
89. K. Liu and Z. H. Fan, The Analyst, 2011, 136, 1288-
1297.
90. R. K. Jena, C. Yue, Y. Lam and Z. Wang, Sensors and 
Actuators B: Chemical, 2010, 150, 692-699.
91. T. M. Valentin, E. M. DuBois, C. E. Machnicki, D. 
Bhaskar, F. R. Cui and I. Y. Wong, Polymer Chemistry, 
2019.
92. Z. Gan, L. Zhang and G. Chen, Electrophoresis, 2011, 
32, 3319-3323.
93. A. E. Vasdekis, M. J. Wilkins, J. W. Grate, R. T. Kelly, 
A. Konopka, S. S. Xantheas and T.-M. Chang, Lab on a 
Chip, 2014, 14, 2072-2080.
94. G. Choi, J. H. Jung, B. H. Park, S. J. Oh, J. H. Seo, J. S. 
Choi and T. S. Seo, Lab on a Chip, 2016, 16, 2309-2316.
Page 11 of 21 Lab on a Chip
ARTICLE Journal Name
12 | J. Name., 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
95. P. L. Quan, M. Sauzade and E. Brouzes, Sensors, 2018, 
18.
96. P. L. Quan, M. Sauzade and E. Brouzes, Sensors 
(Basel), 2018, 18.
97. J.-H. Wang, L. Cheng, C.-H. Wang, W.-S. Ling, S.-W. 
Wang and G.-B. Lee, Biosensors and Bioelectronics, 
2013, 41, 484-491.
98. S. A. Bustin, V. Benes, J. Garson, J. Hellemans, J. 
Huggett, M. Kubista, R. Mueller, T. Nolan, M. W. 
Pfaffl and G. Shipley, Nature Methods, 2013, 10, 
1063-1067.
99. R. T. Hayden, K. M. Hokanson, S. B. Pounds, M. J. 
Bankowski, S. W. Belzer, J. Carr, D. Diorio, M. S. 
Forman, Y. Joshi and D. Hillyard, Journal of clinical 
microbiology, 2008, 46, 157-163.
100. P. J. Sykes, S. H. Neoh, M. J. Brisco, E. Hughes, J. 
Condon and A. A. Morley, Biotechniques, 1992, 13, 
444-449.
101. M. Baker, Nature Methods, 2012, 9, 541-544.
102. B. Vogelstein and K. W. Kinzler, Proceedings of the 
National Academy of Sciences, 1999, 96, 9236-9241.
103. D. Simant, Q. Jian and R. Ramesh, Plos One, 2008, 3, 
e2876.
104. A. S. Whale, S. Cowen, C. A. Foy and J. F. Huggett, PloS 
one, 2013, 8, e58177.
105. A. C. Hatch, J. S. Fisher, A. R. Tovar, A. T. Hsieh, R. Lin, 
S. L. Pentoney, D. L. Yang and A. P. Lee, Lab on a Chip, 
2011, 11, 3838-3845.
106. K. A. Heyries, C. Tropini, M. Vaninsberghe, C. Doolin, 
O. I. Petriv, A. Singhal, K. Leung, C. B. Hughesman and 
C. L. Hansen, Nature Methods, 2011, 8, 649-651.
107. C. A. Milbury, Q. Zhong, J. Lin, M. Williams, J. Olson, 
D. R. Link and B. Hutchison, Biomolecular Detection 
& Quantification, 2014, 1, 8-22.
108. J. de Jong, R. G. H. Lammertink and M. Wessling, Lab 
on a Chip, 2006, 6, 1125-1139.
109. J. C. Linnes, N. M. Rodriguez, L. Liu and C. M. 
Klapperich, Biomedical microdevices, 2016, 18, 1-12.
110. F. Shen, W. B. Du, J. E. Kreutz, A. Fok and R. F. 
Ismagilov, Lab on a Chip, 2010, 10, 2666-2672.
111. Q. Tian, B. Yu, Y. Mu, Y. Xu, C. Ma, T. Zhang, W. Jin 
and Q. Jin, RSC Advances, 2015, 5, 81889-81896.
112. Q. Zhu, L. Qiu, B. Yu, Y. Xu, Y. Gao, T. Pan, Q. Tian, Q. 
Song, W. Jin, Q. Jin and Y. Mu, Lab Chip, 2014, 14, 
1176-1185.
113. Q. Zhu, Y. Xu, L. Qiu, C. Ma, B. Yu, Q. Song, W. Jin, Q. 
Jin, J. Liu and Y. Mu, Lab Chip, 2017, 17, 1655-1665.
114. Y. Ning, X. Cui, C. Yang, F. Jing, X. Bian, L. Yi and G. Li, 
Analytica chimica acta, 2018.
115. C. M. Hindson, J. R. Chevillet, H. A. Briggs, E. N. 
Gallichotte, I. K. Ruf, B. J. Hindson, R. L. Vessella and 
M. Tewari, Nature Methods, 2013, 10, 1003.
116. J. Chen, Z. Luo, L. Li, J. He, L. Li, J. Zhu, P. Wu and L. 
He, Lab on a chip, 2018, 18, 412-421.
117. Z. T. Chen, P. Y. Liao, F. L. Zhang, M. C. Jiang, Y. S. Zhu 
and Y. Y. Huang, Lab on a Chip, 2017, 17, 235-240.
118. K. A. Heyries, C. Tropini, M. VanInsberghe, C. Doolin, 
I. Petriv, A. Singhal, K. Leung, C. B. Hughesman and C. 
L. Hansen, Nature methods, 2011, 8, 649.
119. Z. Cheng, K. Wang, Z. Wu, L. Zhou, Z. Wang, Y. Bai, J. 
Zhao and H. Mao, Sensors & Actuators B Chemical, 
2017.
120. J. Yong, Y. Fang, F. Chen, J. Huo, Q. Yang, H. Bian, G. 
Du and X. Hou, Applied Surface Science, 2016, 389, 
1148-1155.
121. A. Didelot, S. K. Kotsopoulos, A. Lupo, D. Pekin, X. Y. 
Li, I. Atochin, P. Srinivasan, Q. Zhong, J. Olson, D. R. 
Link, P. Laurent-Puig, H. Blons, J. B. Hutchison and V. 
Taly, Clinical Chemistry, 2013, 59, 815-823.
122. Q. Zhong, S. Bhattacharya, S. Kotsopoulos, J. Olson, V. 
Taly, A. D. Griffiths, D. R. Link and J. W. Larson, Lab 
on a Chip, 2011, 11, 2167-2174.
123. J. F. Huggett, C. A. Foy, V. Benes, K. Emslie, J. A. 
Garson, R. Haynes, J. Hellemans, M. Kubista, R. D. 
Mueller and T. Nolan, Clinical chemistry, 2013, 
clinchem. 2013.206375.
124. S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. 
Huggett, M. Kubista, R. Mueller, T. Nolan, M. W. 
Pfaffl and G. L. Shipley, Clinical chemistry, 2009, 55, 
611-622.
125. B. A. Rohrman and R. R. Richards-Kortum, Lab on a 
chip, 2012, 12, 3082-3088.
126. R. K. Daher, G. Stewart, M. Boissinot and M. G. 
Bergeron, Clinical chemistry, 2016, 62, 947-958.
127. Z. A. Crannell, B. Rohrman and R. Richards-Kortum, 
PloS one, 2014, 9, e112146.
128. J. M. Aliotta, J. J. Pelletier, J. L. Ware, L. S. Moran, J. 
S. Benner and H. Kong, Genetic Analysis Biomolecular 
Engineering, 1996, 12, 185.
129. S. Alamer, S. Eissa, R. Chinnappan, P. Herron and M. 
Zourob, Talanta, 2018, 185, 275-280.
130. D. Yuan, J. Kong, X. Li, X. Fang and Q. Chen, Scientific 
reports, 2018, 8, 8682.
131. Y.-D. Ma, W.-H. Chang, K. Luo, C.-H. Wang, S.-Y. Liu, 
W.-H. Yen and G.-B. Lee, Biosensors & bioelectronics, 
2018, 99, 547-554.
132. K. Zhang, D.-K. Kang, M. M. Ali, L. Liu, L. Labanieh, M. 
Lu, H. Riazifar, T. N. Nguyen, J. A. Zell, M. A. Digman, 
E. Gratton, J. Li and W. Zhao, Lab on a Chip, 2015, 15, 
4217-4226.
133. A. Gansen, A. M. Herrick, I. K. Dimov, L. P. Lee and D. 
T. Chiu, Lab on a Chip, 2012, 12, 2247-2254.
134. J. E. Kreutz, J. Wang, A. M. Sheen, A. M. Thompson, J. 
P. Staheli, M. R. Dyen, Q. Feng and D. T. Chiu, Lab on 
a Chip, 2019.
135. S. J. Oh, B. H. Park, G. Choi, J. H. Seo, J. H. Jung, J. S. 
Choi, D. H. Kim and T. S. Seo, Lab on a Chip, 2016, 16, 
1917-1926.
136. S. N, C. J, H. J, L. R, Z. D, G. S, H. J, L. P, Y. L and T. SC, 
Lab on A Chip, 2017, 17, 521.
137. T. N. D. Trinh and N. Y. Lee, Lab on a Chip, 2018.
138. B. Pang, K. Fu, Y. Liu, X. Ding, J. Hu, W. Wu, K. Xu, X. 
Page 12 of 21Lab on a Chip
Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2019, 00, 1-3 | 13
Please do not adjust margins
Please do not adjust margins
Song, J. Wang and Y. Mu, Analytica chimica acta, 
2018, 1040, 81-89.
139. X. Fang, Y. Liu, J. Kong and X. Jiang, Analytical 
chemistry, 2010, 82, 3002-3006.
140. X. Zhi, M. Deng, H. Yang, G. Gao, K. Wang, H. Fu, Y. 
Zhang, D. Chen and D. Cui, Biosensors & 
bioelectronics, 2014, 54, 372-377.
141. K. Hsieh, A. S. Patterson, B. S. Ferguson, K. W. Plaxco 
and H. T. Soh, Angewandte Chemie International 
Edition, 2012, 51, 4896-4900.
142. N. Tomita, Y. Mori, H. Kanda and T. Notomi, Nature 
protocols, 2008, 3, 877.
143. I. Hongwarittorrn, N. Chaichanawongsaroj and W. 
Laiwattanapaisal, Talanta, 2017, 175, 135-142.
144. E.-C. Yeh, C.-C. Fu, L. Hu, R. Thakur, J. Feng and L. P. 
Lee, Science Advances, 2017, 3.
145. S. Lutz, P. Weber, M. Focke, B. Faltin, J. Hoffmann, C. 
Müller, D. Mark, G. Roth, P. Munday and N. Armes, 
Lab on a Chip, 2010, 10, 887-893.
146. J. Song, C. Liu, M. G. Mauk, S. C. Rankin, J. B. Lok, R. 
M. Greenberg and H. H. Bau, Clinical chemistry, 2017, 
63, 714-722.
147. S. Kersting, V. Rausch, F. F. Bier and M. von Nickisch-
Rosenegk, Microchimica Acta, 2014, 181, 1715-1723.
148. Y. Shin, A. P. Perera, K. W. Kim and M. K. Park, Lab on 
a Chip, 2013, 13, 2106-2114.
149. F. Shen, E. K. Davydova, W. Du, J. E. Kreutz, O. 
Piepenburg and R. F. Ismagilov, Analytical chemistry, 
2011, 83, 3533-3540.
150. F. Yin, J. Liu, A. Liu, Y. Li, J. Luo, G. Guan and H. Yin, 
Veterinary parasitology, 2017, 237, 125-129.
151. K. Tae-Hyeong, P. Juhee, K. Chi-Ju and C. Yoon-
Kyoung, Analytical chemistry, 2014, 86, 3841-3848.
152. J. F. C. Loo, H. C. Kwok, C. C. H. Leung, S. Y. Wu, I. L. 
G. Law, Y. K. Cheung, Y. Y. Cheung, M. L. Chin, P. Kwan, 
M. Hui, S. K. Kong and H. P. Ho, Biosensors & 
bioelectronics, 2017, 93, 212-219.
153. G. Huang, Q. Huang, L. Xie, G. Xiang, L. Wang, H. Xu, 
L. Ma, X. Luo, J. Xin, X. Zhou, X. Jin and L. Zhang, 
Scientific Reports, 2017, 7.
154. J. H. Jung, B. H. Park, S. J. Oh, G. Choi and T. S. Seo, 
Biosensors and Bioelectronics, 2015, 68, 218-224.
155. L. Zhang, F. Tian, C. Liu, Q. Feng, T. Ma, Z. Zhao, T. Li, 
X. Jiang and J. Sun, Lab on a Chip, 2018, 18, 610-619.
156. X. Ye, J. Xu, L. Lu, X. Li, X. Fang and J. Kong, Analytica 
chimica acta, 2018, 1018, 78-85.
157. G. Choi, T. Prince, J. Miao, L. Cui and W. Guan, 
Biosensors and Bioelectronics, 2018, 115, 83-90.
158. S. Santiago-Felipe, L. A. Tortajada-Genaro, R. 
Puchades and Á. Maquieira, Microchimica Acta, 2016, 
183, 1195-1202.
159. D. Liu, G. Liang, Q. Zhang and B. Chen, Analytical 
chemistry, 2013, 85, 4698-4704.
160. H. Yang, Z. Chen, X. Cao, Z. Li, S. Stavrakis, J. Choo, P. 
D. Howes and N. He, Analytical and bioanalytical 
chemistry, 2018, 410, 7019-7030.
161. R. Blakemore, E. Story, D. Helb, J. Kop, P. Banada, M. 
R. Owens, S. Chakravorty, M. Jones and D. Alland, 
Journal of clinical microbiology, 2010, 48, 2495-2501.
162. D. Helb, M. Jones, E. Story, C. Boehme, E. Wallace, K. 
Ho, J. Kop, M. R. Owens, R. Rodgers and P. Banada, 
Journal of clinical microbiology, 2010, 48, 229-237.
163. S. Tanriverdi, L. Chen and S. Chen, Journal of 
Infectious Diseases, 2010, 201, S52-S58.
164. N. Brenwald, N. Baker and B. Oppenheim, Journal of 
Hospital Infection, 2010, 74, 245-249.
165. E. M. Harding-Esch, E. C. Cousins, S.-L. Chow, L. T. 
Phillips, C. L. Hall, N. Cooper, S. S. Fuller, A. V. Nori, R. 
Patel and S. Thomas-William, EBioMedicine, 2018, 28, 
120-127.
166. A. Niemz, T. M. Ferguson and D. S. Boyle, Trends in 
biotechnology, 2011, 29, 240-250.
167. H. Wang, Z. Ma, J. Qin, Z. Shen, Q. Liu, X. Chen, H. 
Wang, Z. An, W. Liu and M. Li, Biosensors and 
Bioelectronics, 2019, 126, 373-380.
168. J. R. Choi, Z. Liu, J. Hu, R. Tang, Y. Gong, S. Feng, H. 
Ren, T. Wen, H. Yang and Z. Qu, Analytical chemistry, 
2016, 88, 6254-6264.
Page 13 of 21 Lab on a Chip
ARTICLE Journal Name
14 | J. Name., 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
Figure 1 Conceptual integration of nucleic acid isolation, amplification and the microfluidics 
platform. Improved technologies that promote efficient and clean nucleic acid extraction will 
improve the quality and time cost associated with nucleic acid amplification. Together, these 
approaches applied to the flexibility associated with the microfluidics platform can increase the 
sensitivity, improve the accuracy, reduce time to results, minimize required technical training, and 
improve the development of POC. The end goal is increased treatment efficiency and improved care.
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Figure 2 Magnetic beads-based microfluidic nucleic acid extraction chip. (A) Overview of the TREDA 
system (Shi et al., 2015) (a) schematic of the TREDA chip where (b) controls the dispersion, 
aggregation, and movement of magnetic beads. Adapted from Ref. 34 with permission from the 
Royal Society of Chemistry. (B) Schematic of the DNA extraction process showing (Mosley et al., 
2016) (a) Sample loading and lysis. (b) Mixing of superparamagnetic particles (PMPs) to combine 
with DNA. During the process, the magnet can control the movement of the magnetic beads, so the 
magnetic beads are in an aggregate state. This process can be accelerated by controlling the 
movement of the magnetic beads. (c) Transfer of PMPs through the immiscible phase for washing, 
(d) elution of DNA from the PMPs and collection of the nucleic acid for off-chip analysis is shown. 
Adapted from Ref. 38 with permission from the Royal Society of Chemistry.
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Figure 3 Silica pillar-based nucleic acid extraction method. (A) Silica-coated pillar arrays on 
microchips for DNA extraction (Petralia et al., 2017). The chip is composed of a 6-layer structure and 
the size of silicon pillars array is 5 × 1.8 mm2. Adapted from Ref. 51 with permission from the Royal 
Society of Chemistry. (B) Silicon bead-silicon beads nucleic acid extraction method. Schematic 
illustration of the integrated rotary microdevice for the DNA extraction, the Loop-mediated 
isothermal amplification (LAMP) reaction, and the lateral flow strip detection are shown (Park et al., 
2017). Nucleic acid extraction is based on the Silica microbead-bed channel, which serves as a solid 
phase matrix. DNA extraction is achieved by controlling different speeds and the extraction efficiency 
can be up to 80% in the microdevice. Adapted from Ref. 48 with permission from Elsevier.
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Figure 4 Chitosan-modified Fusion 5 filter paper and DNA capture mechanism (Gan et al., 2017). 
(A) 3-mm-diameter discs of chitosan-modified Fusion 5 filter paper. Schematic and scanning 
electron microscope image of the fiber matrix coated with chitosan polymers. (B) Schematic of 
the DNA capture mechanism. At a pH around 5, DNA molecules are “actively” adsorbed onto the 
chitosan-modified fibers. Once DNA is on the fibers, the physical entanglement of the long-chain 
molecules with the fiber matrix can also assist the capture. At a pH of 9, although DNA is not 
“actively” absorbed onto the fiber, DNA molecules remain bound due to the physical trapping of 
these long-chain DNA molecules within the fiber matrix against washing and elution. Adapted 
from Ref. 63 with permission from ACS Publications. 
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Figure 5 Schematic of DMA chip and DMP chip for nucleic acid extraction. (A) DMA chip for 
RNA isolation. a:Cell lysis. Different components including DNA, RNA and protein are released. 
b:on-chip RNA isolation. RNA is bound and eluted by controlling pH. Adapted from Ref. 79 with 
permission from the Elsevier. (B) DMP chip for DNA and RNA isolation. (a) Chemical structure 
of DMP and schematic drawing for assembling of a plastic type microfluidic cartridge with a 3D 
disposable chip. (b) schematic and photograph workflows for the DMP system for RNA (b) and 
DNA (c) extraction. Adapted from Ref. 20 with permission from ACS Publications.
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Figure 6 Schematic drawing of the fractal branching microchannel net chip (Zhu et al., 2017). (A) 
Schematic diagram of the chip that has 4096 microwells for dPCR reaction. (B) Diagram of the details of 
the chip design. (C) Photograph of the chip. (D) The scalability of the chip with 16384 microwells in each 
reaction panel. (E) The principle and operation procedure of the microfluidic device: (a) the chip is 
degassed in a vacuum pump and then adhesive tape is attached to seal the top surface of the chip after 
the degassing step; (b) the adhesive tape is punctured, and the reagent can be dispensed into the inlet, 
while the degassing-drive flow primes the sample into the microwells quickly; (c) the oil is then dispensed 
into the inlet, and the oil phase is self-primed into the channels; (d) all the sample solutions are partitioned 
into each microwell by the oil, and no sample is wasted. Finally, the chip is sealed using a coverslip to run 
PCR amplification. Adapted from Ref. 113 with permission from the Royal Society of Chemistry.
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Figure 7 Technical variance for the INEAD and SIDAO systems. (A) The paper-based INEAD system (Connelly et al., 2015) is 
shown for comparison with the (B) centrifugal microfluidic that integrates the nucleic acid extraction with LAMP (Loo et al., 
2016) and (C) the capillary-based INEAD system (Liu et al., 2013). “A” has the advantage of low cost while “B” and “C” can be 
automated. Despite the different integration options of the microfluidic chip, the systems can be simple and fast to achieve 
“sample-in-answer-out”. (D) The magnetic bead-based system combines nucleic acid extraction with a digital Recombinase 
Polymerase Amplification (RPA) chip (Yang et al., 2018). “D” can automatically achieve “sample-in-digital-answer-out”. Figure 
A and C are adapted from Ref. 53 and Ref.159 with permission from ACS Publications, Figure B is adapted from Ref. 152 with 
permission from Elsevier, and Figure D is adapted from Ref. 160 with permission from Springer.
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Integrated microfluidic systems with sample preparation and nucleic acid amplification can 
increased treatment efficiency and improved care.
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